Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Clinical trial NCT01211639 · TERMINATED
Trial details
- NCT number
- NCT01211639
- Sponsor
- Biogen
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.